Those snip snips you keep throwing out must be your brain cells falling out of your head. IBIO does not own any drug associated with Ebola. Their patent covers the process that cures derivatives of the tobacco plant in order to process a drug called ZMapp (the most effective treatment of Ebola). Any company who attempts to use this process (which is the only viable way yet known to produce ZMapp on a large scale) will have to have permission in some form from IBIO. This is a fact. They do not own the drug or anything else related to Ebola. But they will benefit from the production of ZMapp just because of the process related to making it. Next financials will show this IMO.
I don't see the problem, legal or otherwise. Their process has a wide application...including Ebola...which is all they said. Investors asked " could your process be used to make Ebola antigens?" The answer is "yes it could, but is not currently." The rest is speculation, which is what we are doing here.
News 
Market Data 
Discover 
